- Ukwelashwa
- Ubufakazi
- I-Neuroblastoma
- Isimila Esiqinile
- Ubufakazi
- I-TILS
- Ukwelashwa Kwamaseli e-NK
- I-Myasthenia Gravis (MG)
- I-Acute Lymphoblastic Leukemia (B-ALL)
- I-Systemic Lupus Erythematosus (SLE)
- I-Acute Lymphoblastic Leukemia (T-ALL)
- I-Non-Hodgkin Lymphoma (NHL)
- I-Multiple Myeloma (MM)
- I-Diffuse Large B-cell Lymphom
- I-B-lymphocytic Leukemia
- I-Myeloma
I-Acute Lymphoblastic Leukemia (T-ALL)-06
Isiguli sezingane esineminyaka emibili ubudala esine-T-ALL sithola ukuphulukiswa ngemva kokwelashwa nge-CAR-T ngemuva kokwelashwa ngamakhemikhali anamandla angaphezu kweshumi.
UXiaohong oneminyaka emibili ubudala waseZhejiang watholakala enesifo somdlavuza wegazi ehlobo eledlule. Ngemva kokwelashwa isikhathi esingaphezu konyaka, i-flow cytometry yathola ukuthi isifo siphinde sibuye, okwaholela umndeni ekufuneni i-CAR-T immunotherapy kwa-BIOOCUS Medical Group.
Ngo-Agasti 9, 2020, uXiaohong wangeniswa esibhedlela sezingane sendawo ngenxa "yomkhuhlane wezinsuku ezintathu." Ukuhlolwa kwe-MICM yomnkantsha kwathola ukuthi i-acute lymphoblastic leukemia (T-ALL). Ngemva kwenkambo eyodwa yokwelashwa ngamakhemikhali, i-bone marrow morphology yabonisa ukuphulukiswa okuphelele, kanti i-flow cytometry ayizange ithole amangqamuzana amabi angakavuthwa. I-chemotherapy enamandla eyalandela ngaphezu kwezifundo ezingu-11 yagcina ukuphulukiswa okuphelele komnkantsha.
NgoSepthemba 3, 2021, ukubhobozwa komnkantsha okulandelayo kwabonisa ukuxolelwa okuphelele ku-morphology, kodwa i-flow cytometry yaveza amangqamuzana angakavuthwa angu-1.85%. Efuna ukwelashwa okwengeziwe, uXiaohong wangeniswa esikhungweni sethu se-CGT ngoSepthemba 24. Lapho engeniswa, i-morphology yomnkantsha yayisesekuxolelwe okuphelele, kodwa i-immunophenotyping yabonisa ukuthi ama-lymphocyte e-T angakavuthwa angu-0.10%.
Uma sibheka iminyaka kaXiaohong esemncane kanye nokuqhubeka kwalesi sifo naphezu kokwelashwa ngamakhemikhali okunamandla okungaphezu kweshumi, ithimba lezokwelapha egunjini lesibili lomnyango we-hematology lanquma ukuthi uXiaohong angabhalisa esivivinyweni somtholampilo se-CD7 CAR-T.
NgoSepthemba 30, 2021, kwaqoqwa amaseli egazi angaphandle ukuze kukhiqizwe isiko lamaseli e-CAR-T. Ngo-Okthoba 10, uXiaohong wathola i-FC regimen chemotherapy. Ngo-Okthoba 13, ukubhobozwa komnkantsha kwabonisa ukuqhuma okungaphansi kuka-5% ku-morphology, kanti i-flow cytometry yabonisa amaseli e-T angakavuthwa angama-0.37%. Ngo-Okthoba 15, amaseli e-CD7 CAR-T aphinde afakwa.
Ngomhlaka-3 Januwari (izinsuku ezingu-20 ngemuva kokufakwa kabusha), ukubhobozwa komnkantsha kwabonisa ukuphulukiswa okuphelele kokwakheka, kungekho maseli angakavuthwa atholakala yi-flow cytometry. Isimo sikaXiaohong sesizinzile kusukela lapho, futhi udluliselwe emnyangweni wokufakelwa ukuze alungiselele ukufakelwa kweseli le-hematopoietic stem cell.
UXiaohong wayengaphansi konyaka ubudala lapho egula futhi wabekezelela ukwelashwa ngemithi isikhathi esingaphezu konyaka. Ukuphumelela kokuhlangana nokufakelwa izicubu ngemuva kokwelashwa nge-CD7 CAR-T kuye kwanikeza isikhali esinamandla sokunqoba lesi sifo ngokuphelele.
incazelo2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

